Publicacions en col·laboració amb investigadors/es de Hospital del Mar (18)

2024

  1. Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder

    Alcohol, Clinical and Experimental Research, Vol. 48, Núm. 7, pp. 1313-1321

  2. Substance use disorders and cooperative research on addictions: Spanish approach as a model

    Pharmacological Research, Vol. 206

2022

  1. Acute stress and alcohol exposure during adolescence result in an anxious phenotype in adulthood: Role of altered glutamate/endocannabinoid transmission mechanisms

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113

2020

  1. Impact of intermittent voluntary ethanol consumption during adolescence on the expression of endocannabinoid system and neuroinflammatory mediators

    European Neuropsychopharmacology, Vol. 33, pp. 126-138

  2. Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders

    PLoS ONE, Vol. 14, Núm. 3

  2. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants

    Neuropharmacology, Vol. 149, pp. 212-220

2018

  1. Octadecylpropyl sulfamide reduces neurodegeneration and restores the memory deficits induced by hypoxia-ischemia in mice

    Frontiers in Pharmacology, Vol. 9, Núm. APR

2016

  1. Can symptoms help in differential diagnosis between substance-induced vs independent psychosis in adults with a lifetime diagnosis of cocaine use disorder?

    Psychiatry Research, Vol. 242, pp. 94-100

2015

  1. Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context

    Frontiers in Cellular Neuroscience, Vol. 9

  2. Plasma Concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: Relationship to psychiatric comorbidity

    PLoS ONE, Vol. 10, Núm. 3

  3. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: Influence of cocaine symptom severity and psychiatric co-morbidity

    Addiction Biology, Vol. 20, Núm. 4, pp. 756-772

  4. Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings

    Frontiers in Psychiatry, Vol. 6, Núm. FEB

  5. Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats

    DMM Disease Models and Mechanisms, Vol. 8, Núm. 10, pp. 1213-1225

2013

  1. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats

    European Journal of Neuroscience, Vol. 37, Núm. 1, pp. 105-117

  2. Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: Impact of psychiatric co-morbidity

    Addiction Biology, Vol. 18, Núm. 6, pp. 955-969

2012

  1. Unsaturated fatty alcohol derivatives of olive oil phenolic compounds with potential low-density lipoprotein (LDL) antioxidant and antiobesity properties

    Journal of Agricultural and Food Chemistry, Vol. 60, Núm. 4, pp. 1067-1074

2010

  1. Synthesis of fatty acid amides of catechol metabolites that exhibit antiobesity properties

    ChemMedChem, Vol. 5, Núm. 10, pp. 1781-1787